[
  {
    "ts": null,
    "headline": "Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade)",
    "summary": "Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity. Click here to read why VKTX is a Buy.",
    "url": "https://finnhub.io/api/news?id=ec3a005b2a5023dda2ad92ae7ddeb69830a5da30dcfb96186e3126d77332b8f6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741696999,
      "headline": "Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade)",
      "id": 133135944,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2162809200/image_2162809200.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity. Click here to read why VKTX is a Buy.",
      "url": "https://finnhub.io/api/news?id=ec3a005b2a5023dda2ad92ae7ddeb69830a5da30dcfb96186e3126d77332b8f6"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Charter Fund Q4 2024 Commentary",
    "summary": "Invesco Charter Fund Q4 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=95c0176b47e7774f20184f6f2a105120cd484938174680e245d9781e4ecb23ba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741689000,
      "headline": "Invesco Charter Fund Q4 2024 Commentary",
      "id": 133135154,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=95c0176b47e7774f20184f6f2a105120cd484938174680e245d9781e4ecb23ba"
    }
  },
  {
    "ts": null,
    "headline": "Merck opens vaccine manufacturing facility in North Carolina",
    "summary": "Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. ...",
    "url": "https://finnhub.io/api/news?id=ed71b4f0a7b63411271f5fc6937a3373ff5e5c2a814bc48eeef92d0d671fde65",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741678004,
      "headline": "Merck opens vaccine manufacturing facility in North Carolina",
      "id": 133131532,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. ...",
      "url": "https://finnhub.io/api/news?id=ed71b4f0a7b63411271f5fc6937a3373ff5e5c2a814bc48eeef92d0d671fde65"
    }
  }
]